Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
28 pending office actions • 20 art units • 26 examiners • 0 of 28 (0%) have an AI response strategy ready • 34 patents granted in the last 365 days
Universiteit Gent currently has 29 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 29 pending office actions are distributed among 27 distinct examiners, showing that most examiners are handling a single matter for the university. The prosecution efforts are spread across 21 distinct art units, which highlights the diverse biological and pharmaceutical innovations being pursued. This distribution across 21 distinct art units suggests that the portfolio covers a broad spectrum of scientific disciplines.
The busiest examiner for the portfolio is LIU, TRACY, who is managing 2 busiest examiner pending actions. While this is the highest concentration for any single examiner, it represents a portion of the 29 pending office actions. Practitioners managing this portfolio must navigate the specific requirements of 21 distinct art units, necessitating a versatile approach to responding to office actions. The presence of 27 distinct examiners across the pending actions indicates a decentralized prosecution environment where individual examiner trends will vary significantly.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (7%) |
| §103 only | 8 (29%) |
| §102 only | 1 (4%) |
| §112 only | 4 (14%) |
| Double-patenting + other | 5 (18%) |
| Multi-statute (no §101) | 8 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIU, TRACY | 2 | 54.5% | +27.3% |
| PATTERSON, SARAH COOPER | 2 | 55.3% | +59.5% |
| KU, SI MING | 1 | 72.7% | +32.7% |
| BEYEN, ZEWDU A | 1 | 83.5% | +14.8% |
| ARIANI, KADE | 1 | 74.9% | +32.4% |
| HUSON, MONICA ANNE | 1 | 79.6% | +13.5% |
| JONES, DAMERON LEVEST | 1 | 67.7% | +31.3% |
| WEISSBERGER, LUNA T | 1 | 75.1% | +24.5% |
| LANDSMAN, ROBERT S | 1 | 81.3% | +13.0% |
| COLLINS, CYNTHIA E | 1 | 82.2% | +9.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691384 | AMINOPEPTIDASE N-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF | LANDSMAN, ROBERT S | — |
| 18600428 | Means and Methods for Improved Regeneration | COLLINS, CYNTHIA E | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17784859 | NON-VIRAL VECTORS COMPRISING POLYPROPYLENEIMINE | BOATENG, AFUA BAMFOAA | 67d overdue |
| 18857976 | MEDICAL IMPLANT FOR TREATMENT OF A SCAPULA FRACTURE | KU, SI MING | — |
| 18853638 | IMPACTLESS ASSOCIATING IN A WIRELESS TIME SENSITIVE NETWORK | BEYEN, ZEWDU A | — |
| 18723470 | Microbial communities | ARIANI, KADE | — |
| 18429576 | LASER APPARATUS AND METHOD FOR CONTROLLING THE LINEWIDTH OF THE EMITTED LASER BEAM | HUGHES, DEANDRA M | — |
| 18571533 | COMPOSITION AND PROCESS FOR AN INFILTRATION AND TRANSPORT MEDIUM FOR ADIPOSE TISSUE CELLS | NOBLE, MARCIA STEPHENS | — |
| 18549476 | TREATMENT OF EYE DISEASES WITH FRUCTOSYL-AMINO ACID OXIDASE | FAN, LYNN Y | — |
| 18261292 | A METHOD TO PREPARE POCKETS OF ENCAPSULATED MATERIAL COMPRISING A CORE SURROUNDED BY AN ENCAPSULATION | ANGEBRANNDT, MARTIN J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18029518 | Prebiotic Oral Care Compositions and Methods | LIU, TRACY | 15d |
| 18857976 | MEDICAL IMPLANT FOR TREATMENT OF A SCAPULA FRACTURE | KU, SI MING | — |
| 18853638 | IMPACTLESS ASSOCIATING IN A WIRELESS TIME SENSITIVE NETWORK | BEYEN, ZEWDU A | — |
| 18723470 | Microbial communities | ARIANI, KADE | — |
| 18722254 | SOLUTION ELECTROSPUN FIBERS, COMPOSITIONS COMPRISING THE SAME AND A PROCESS OF MANUFACTURING THEREOF | HUSON, MONICA ANNE | — |
| 18711699 | HAFNIUM (IV) OXIDE NANOPARTICLES AND AQUEOUS COMPOSITIONS THEREOF | JONES, DAMERON LEVEST | — |
| 18698080 | DEVICE AND METHOD FOR CLOCK SYNCHRONISATION IN A WIRELESS NETWORK | WEISSBERGER, LUNA T | — |
| 18691384 | AMINOPEPTIDASE N-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF | LANDSMAN, ROBERT S | — |
| Art Unit | Apps |
|---|---|
| 1614 | 3 |
| 1691 | 2 |
| 1675 | 2 |
| 3775 | 1 |
| 1651 | 1 |
| 1742 | 1 |
| 2415 | 1 |
| 1662 | 1 |
| 1632 | 1 |
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18857976 | MEDICAL IMPLANT FOR TREATMENT OF A SCAPULA FRACTURE | KU, SI MING | 3775 | §102§103 | Non-Final OA | — | Pending | Oct 18, 2024 |
| 18853638 | IMPACTLESS ASSOCIATING IN A WIRELESS TIME SENSITIVE NETWORK | BEYEN, ZEWDU A | — | §101§102§103 | Non-Final OA | — | Pending | Oct 02, 2024 |
| 18723470 | Microbial communities | ARIANI, KADE | 1651 | §103§112 | Non-Final OA | — | Pending | Jun 24, 2024 |
| 18722254 | SOLUTION ELECTROSPUN FIBERS, COMPOSITIONS COMPRISING THE SAME AND A PROCESS OF MANUFACTURING THEREOF | HUSON, MONICA ANNE | 1742 | §103 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18711699 | HAFNIUM (IV) OXIDE NANOPARTICLES AND AQUEOUS COMPOSITIONS THEREOF | JONES, DAMERON LEVEST | — | §112 | Non-Final OA | — | Pending | May 20, 2024 |
| 18698080 | DEVICE AND METHOD FOR CLOCK SYNCHRONISATION IN A WIRELESS NETWORK | WEISSBERGER, LUNA T | 2415 | §103 | Final Rejection | — | Pending | Apr 03, 2024 |
| 18691384 | AMINOPEPTIDASE N-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF | LANDSMAN, ROBERT S | — | §112 | Non-Final OA | — | Pending | Mar 12, 2024 |
| 18600428 | Means and Methods for Improved Regeneration | COLLINS, CYNTHIA E | 1662 | §102§103§112DP | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18429576 | LASER APPARATUS AND METHOD FOR CONTROLLING THE LINEWIDTH OF THE EMITTED LASER BEAM | HUGHES, DEANDRA M | — | §102§112 | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18571533 | COMPOSITION AND PROCESS FOR AN INFILTRATION AND TRANSPORT MEDIUM FOR ADIPOSE TISSUE CELLS | NOBLE, MARCIA STEPHENS | 1632 | §102§103§112 | Non-Final OA | — | Pending | Dec 18, 2023 |
| 18570876 | Means and Methods to Regulate Gut Dysbiosis | LEWIS, PATRICK T | 1691 | §112 | Final Rejection | — | Pending | Dec 15, 2023 |
| 18552838 | MEANS AND METHOD FOR CYTOSOLIC DELIVERY | HAGHIGHATIAN, MINA | 1616 | §103 | Final Rejection | 12d | Pending | Sep 27, 2023 |
| 18549476 | TREATMENT OF EYE DISEASES WITH FRUCTOSYL-AMINO ACID OXIDASE | FAN, LYNN Y | 1759 | §101§102§103 | Non-Final OA | — | Pending | Sep 07, 2023 |
| 18547111 | Cation-Independent Mannose-6-Phosphate Receptor Binders | CHASE, CAROL ANN | 1646 | §102§103§112DP | Non-Final OA | — | Pending | Aug 18, 2023 |
| 18261292 | A METHOD TO PREPARE POCKETS OF ENCAPSULATED MATERIAL COMPRISING A CORE SURROUNDED BY AN ENCAPSULATION | ANGEBRANNDT, MARTIN J | 1737 | §103§112 | Non-Final OA | — | Pending | Jul 13, 2023 |
| 18260942 | SEALING STRIP FOR SEALING JOINTS BETWEEN THE SURFACES OF TWO ADJACENT COMPONENTS | KENNY, DANIEL J | 3633 | §103 | Final Rejection | — | Pending | Jul 11, 2023 |
| 18265366 | IONIZABLE LIPIDS | CARR, DEBORAH D | 1691 | §112 | Non-Final OA | — | Pending | Jun 05, 2023 |
| 18142147 | METHOD FOR DEPOSITING A RUTHENIUM-CONTAINING FILM ON A SUBSTRATE BY A CYCLICAL DEPOSITION PROCESS | CHEN, BRET P | 1718 | §102§112DP | Non-Final OA | 3d overdue | Pending | May 02, 2023 |
| 18029518 | Prebiotic Oral Care Compositions and Methods | LIU, TRACY | 1614 | §103 | Non-Final OA | 15d | Pending | Mar 30, 2023 |
| 18040402 | BACTERIAL COMPOSITIONS WITH ANTI-INFLAMMATORY ACTIVITY | GANGLE, BRIAN J | 1645 | §102§112 | Final Rejection | — | Pending | Feb 02, 2023 |
| 18048946 | TOOLS AND METHODS FOR EXPRESSION OF MEMBRANE PROTEINS | PAK, MICHAEL D | 1674 | §112DP | Non-Final OA | — | Pending | Oct 24, 2022 |
| 17920413 | METHOD FOR LAYER-BY-LAYER DEPOSITION OF CONCRETE | INSLER, ELIZABETH | 1774 | §102 | Final Rejection | — | Pending | Oct 21, 2022 |
| 17907717 | A METHOD TO DEINK PLASTIC MATERIAL | RIVERA-CORDERO, ARLYN I | 1714 | §103 | Final Rejection | — | Pending | Sep 29, 2022 |
| 17784859 | NON-VIRAL VECTORS COMPRISING POLYPROPYLENEIMINE | BOATENG, AFUA BAMFOAA | 1614 | §103§112 | Non-Final OA | 67d overdue | Pending | Jun 13, 2022 |
| 17745307 | TARGETED CHIMERIC PROTEINS AND USES THEREOF | PATTERSON, SARAH COOPER | 1675 | §112DP | Final Rejection | — | Pending | May 16, 2022 |
| 17442772 | FMS-LIKE TYROSINE KINASE 3 LIGAND (FLT3L)-BASED CHIMERIC PROTEINS | PATTERSON, SARAH COOPER | 1675 | §103§112 | Non-Final OA | — | Pending | Sep 24, 2021 |
| 17248815 | Prebiotic Oral Care Compositions Containing Carboxylic Acids | LIU, TRACY | 1614 | §103 | Non-Final OA | — | Pending | Feb 09, 2021 |
| 17128599 | BISPECIFIC SIGNALING AGENTS AND USES THEREOF | GAO, ASHLEY HARTMAN | 1678 | §103Other | Non-Final OA | 33d | Pending | Dec 21, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial